|Day Low/High||1.08 / 1.12|
|52 Wk Low/High||0.81 / 12.80|
Pain Therapeutics plunges after a trial of its pain drug fails to show statistical significance.
With a 4% budget surplus, Chile is hot with investment opportunities, says Cramer.
Pain Therapeutics jumps on King alliance, while Eyetech drops on concerns over its deal with OSI.
Understand what's behind these lines by looking at Google, Research In Motion and others.
Remoxy looks interesting, but it's premature to call this a holy grail.
Some analysts say Sunrise Telecom is a buy. But now, more than 90% of its outstanding shares are being released.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.